Company: LASE
Filing Date: 2025-06-24
Form Type: 10-K
Source: 0001641172-25-016194
Chunk: 208

Company: Laser Photonics Corp
Filing Date: 2025-06-24
Form: 10-K
Item: Item 1
Chunk 208
---
 compromised. If there are material defects in the form or preparation of our patents or patent applications, such patents or applications
may be invalid and unenforceable. Any of these outcomes could impair our ability to prevent competition from third parties, which may
harm our business.

The
patent applications that we may own, or license may fail to result in issued patents in the United States or in other countries. Even
if patents are issued on such patent applications, third parties may challenge the validity, enforceability or scope thereof, which may
result in such patents being narrowed, invalidated or held unenforceable. For example, U.S. patents can be challenged by any person before
the new USPTO Patent Trial and Appeals Board at any time within the first year of that person’s receipt of an allegation of infringement
of the patents. Patents granted by the European Patent Office may be similarly opposed by any person within nine months from the publication
of the grant. Similar proceedings are available in other jurisdictions, and in the United States, Europe and other jurisdictions third
parties can raise questions of validity with a patent office even before a patent has granted. Furthermore, even if they are unchallenged,
our patents and patent applications may not adequately protect our intellectual property or prevent others from designing around our
claims. If the breadth or strength of protection provided by the patents and patent applications we hold or pursue with respect to our
product candidates is successfully challenged, then our ability to commercialize such product candidates could be negatively affected,
and we may face unexpected competition that could harm our business. Further, if we encounter delays in our clinical trials, the period
of time during which we or our collaborators could market our product candidates under patent protection would be reduced.

24

The
degree of future protection of our proprietary rights is uncertain. Patent protection may be unavailable or severely limited in some
cases and may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example:

    ●
    we
    might not have been the first to invent or the first to file the inventions covered by each of our pending patent applications and
    issued patents;

    ●
    others
    may be able to make, use, sell, offer to sell or import products that are similar to our products or product candidates but that
    are not covered by the claims of our patents; others may independently develop similar or alternative technologies or duplicate any
    of our technologies;

    ●
    the